Search clinical trials for: pancreatic tumour

Total 8259 results

Ipsen

Completed

Study of Lanreotide Autogel 120 mg in Patients With Non-functioning Entero- Pancreatic Endocrine Tumour (NET729)

Non Functioning Entero-pancreatic Endocrine Tumour

United Kingdom, France, Spain, United States, Belgium, Czechia, Italy, Slovakia, Poland
Ipsen

Completed

Study of Lanreotide Autogel in Non-functioning Entero-pancreatic Endocrine Tumours (CLARINET)

Endocrine Tumors

United States, United Kingdom, Netherlands, Belgium, Sweden, Spain, France, Denmark, India, Germany, Austria, Czechia, Italy, Poland, Slovakia
Ipsen

Completed

Efficacy and Safety Study in Pancreatic or Midgut Neuroendocrine Tumours Having Progressed Radiologically While Previously Treated With Lanreotide Autogel® 120 mg (CLARINET FORTE)

Midgut Neuroendocrine Tumours | Pancreatic Tumours

Spain, United Kingdom, Denmark, Belgium, Germany, France, Netherlands, Ireland, Italy, Poland
Australasian Gastro-Intestinal Trials Group

Completed

Capecitabine ON Temozolomide Radionuclide Therapy Octreotate Lutetium-177 NeuroEndocrine Tumours Study (CONTROL NETS)

Midgut Neuroendocrine Tumours | Pancreatic Neuroendocrine Tumours

Australia
Centre Hospitalier Universitaire Dijon

Terminated

Viewpoints on the Social Representations and Rationale Concerning the Choices of Patients, Doctors and Caregivers With Regard to the Management of Patients With Non-resectable Metastatic Cancer of the Colon, Stomach, Bile Ducts, Rectum, Pancreas or Lung, or Gastrointestinal Neuroendocrine Tumours (EOLE)

Non-resectable Metastatic Cancer of the Lung | Non-resectable Metastatic Cancer of the Colon | Non-resectable Metastatic Cancer of the Rectosigmoid Junction | Non-resectable Metastatic Cancer of the Stomach | Non-resectable Metastatic Cancer of the Bile Duct | Non-resectable Metastatic Cancer... and other conditions

France
Philogen S.p.A.

Terminated

Combination Therapy of L19IL2 and Gemcitabine in Advanced Pancreatic Cancer Patients

Pancreatic Cancer Patients Diagnosed With Locally Advanced or Metastatic Pancreatic Cancer Not Amenable to Curative Surgical Resection

Italy, Germany
University Medical Center Groningen
Radboud University Medical Center; Universitaire Ziekenhuizen KU Leuven; Amsterdam...

Completed

Social Cognition in Children Treated for a Brain Tumour

Brain Neoplasms | Cystic Fibrosis | Social Behaviour

Belgium, Netherlands
OncoSil Medical Limited

Completed

A Pilot Study of OncoSil™ Given to Patients With Pancreatic Cancer Treated With FOLFIRINOX or Gemcitabine+Abraxane (PanCO)

Unresectable Locally Advanced Pancreatic Carcinoma

United Kingdom, Belgium, Australia
OncoSil Medical Limited

Completed

A Pilot Study of OncoSil™ Given to Patients With Pancreatic Cancer Treated With Gemcitabine +/- Nab-paclitaxel. (OncoPaC-1)

Unresectable Locally Advanced Pancreatic Carcinoma

United States
Ipsen

Terminated

Lanreotide 120mg Effectiveness in Subjects With Pancreatic Neuroendocrine Tumours (PanNET) in Routine Clinical Practice. (PanNET)

Pancreatic Neuroendocrine Tumor

Spain, Portugal
Grupo Espanol de Tumores Neuroendocrinos
Pfizer

Active, not recruiting

Sandostatin LAR and Axitinib vs Pbo in Pnts With Advanced Well-differentiated Non-pancreatic Neuroendocrine Carcinomas

Neuroendocrine Tumors | Advanced Cancer

Spain, Germany, Italy, United Kingdom
Ipsen

Completed

Quality-Of-Life QLQ-GINET21 Questionnaire In The Treatment Of Patients With Gastrointestinal Neuroendocrine Tumours (QUALINETS)

Gastrointestinal Neuroendocrine Tumours

Spain, Portugal
University of Warmia and Mazury
National Center for Research and Development, Poland; Medical University of... and other collaborators

Unknown

Personalized CAPTEM Radiopeptide Therapy of Advanced, Non-resectable Neuroendocrine Cancer

Neuroendocrine Tumors

Poland
Per Pfeiffer

Completed

Chemotherapy for Patients With Locally Advanced Pancreatic Cancer (LAPC) With Additional Chemo-radiotherapy (CRT) for Patients With Borderline Resectable Tumours

Pancreatic Cancer

Denmark
Grupo Espanol de Tumores Neuroendocrinos
Pfizer; Threshold Pharmaceuticals

Completed

A Study to Assess the Safety and the Efficacy of the Combination of TH-302 and Sunitinib in Neuroendocrine Pancreatic Tumours

Pancreatic Neoplasms | Neuroendocrine Tumors

Spain
Ipsen

Completed

Quality of Life, Treatment Experience and Cost of Treatment With Somatostatin Analogues in Patients With Gastroenteropancreatic Neuroendocrine Tumours (STREET)

Gastroenteropancreatic Neuroendocrine Tumours

Sweden
Royal Free Hospital NHS Foundation Trust

Unknown

Portal Vein Resection in Pancreatic Neuroendocrine Tumours (PVNET)

Neuroendocrine Tumors | Pancreas Neoplasm
University of Warmia and Mazury
Stowarzyszenie Pacjentów i Osób Wspierających Chorych na Guzy Neuroendokrynne

Unknown

Peptide Receptor Radionuclide Therapy in the Treatment of Advanced, Non-resectable and/or Symptomatic Tumors With SSTR Overexpression (POLNETS_PRRT)

Neuroendocrine Tumors

Poland
Grupo Espanol de Tumores Neuroendocrinos
Pfizer; Apices Soluciones S.L.

Completed

Efficacy of Rechallenge With Sunitinib in Metastatic Pancreatic Neuroendocrine Tumor Previously Failed to Sunitinib (RESUNET)

Pancreatic Neuroendocrine Tumour Metastatic

Spain
Royal Marsden NHS Foundation Trust

Unknown

A Prospective Translational Tissue Collection Study in Early and Advanced Pancreatic Ductal Adenocarcinoma and Pancreatic Neuroendocrine Tumours to Enable Further Disease Characterisation and the Development of Potential Predictive and Prognostic Biomarkers (PaC-MAn)

Pancreatic Adenocarcinoma

United Kingdom
AstraZeneca

Completed

A Study to Assess the Safety, Tolerability and Anti-tumour Activity of Ascending Doses of Selumetinib in Combination With MEDI4736 and Selumetinib in Combination With MEDI4736 and Tremelimumab in Patients With Advanced Solid Tumours

Melanoma | Breast Cancer | Colorectal Cancer | Pancreatic Adenocarcinoma | Lung Cancer | Head and Neck Carcinoma | Biliary Tract Cancer | Gastroesophageal Cancer

United States
University College, London

Unknown

A Phase II Multicentre Trial of Endoscopic Ultrasound Guided Radiofrequency Ablation of Cystic Tumours of the Pancreas (RADIOCYST01)

Pancreatic Cyst

United Kingdom, Australia
University College, London
Cambridge University Hospitals NHS Foundation Trust

Completed

A Phase II MULTICENTRE Trial of Needle Based Laser Confocal Endomicroscopy of Cystic and Solid Tumours of the Pancreas (CONCYST)

Pancreatic Cyst | Cystadenoma, Mucinous | Intraductal Papillary Mucinous Neoplasm | Serous Cystadenoma

United Kingdom
European Institute of Oncology

Completed

A Biological Prospective Study in Patients With Metastatic Pancreatic NETs Treated With Everolimus

Pancreatic Neuroendocrine Tumour Metastatic

Italy
Arcispedale Santa Maria Nuova-IRCCS

Completed

68-Ga-labeled Octreotide Analogues PET in Duodenal-pancreatic Neuroendocrine Tumours

Neuroendocrine Tumours

Austria, Italy
British Columbia Cancer Agency
BC Cancer Foundation; Pancreatic Cancer Canada

Unknown

The Effects of Neoadjuvant Metformin on Tumour Cell Proliferation and Tumour Progression in Pancreatic Ductal Adenocarcinoma (Metformin 001)

Resectable Pancreatic Ductal Adenocarcinoma

Canada
University of Medicine and Pharmacy Craiova
M.D. Anderson Cancer Center; Massachusetts General Hospital; University College... and other collaborators

Terminated

Needle-based Confocal Laser Endomicroscopy on Pancreatic Cystic Lesions (CINE-Cyst)

Cystadenocarcinoma | Pancreatic Mucinous-Cystic Neoplasm | Pancreatic Cysts | Intraductal Papillary Mucinous Neoplasm | Solid Pseudopapillary Tumour of the Pancreas | Serous Cystadenoma

United States, Denmark, Romania, United Kingdom
GlaxoSmithKline

Completed

Trial of GSK1120212 and GSK1120212 in Combination With GEM in Japanese Subjects With Solid Tumors

Solid Tumours

Japan
Uppsala University

Unknown

Biomarker Study in Pancreatic Neuroendocrine Tumours (PROGRESS)

Neuroendocrine Tumors

Sweden
Spanish Cooperative Group for the Treatment of...
Hoffmann-La Roche

Completed

Safety and Efficacy Study of Gemcitabine-erlotinib Versus Gemcitabine-erlotinib-capecitabine in Patients With Metastatic Pancreatic Cancer (GECA)

Metastatic Pancreatic Cancer

Spain
PD Dr. med. Volker Heinemann
Boehringer Ingelheim

Unknown

Afatinib as Cancer Therapy for Exocrine Pancreatic Tumours (ACCEPT)

Focus of Study Instead

Germany
Maastricht University Medical Center

Unknown

Everolimus TDM to Predict Long Term Toxicity (Foresight)

Renal Cell Carcinoma | Breast Cancer | Neuroendocrine Neoplasm of Lung | Pancreatic Neuroendocrine Tumour | Gastrointestinal Neuroendocrine Tumour

Netherlands
Lightpoint Medical Limited
Semmelweis University

Withdrawn

Use of the EnLightTM and LightPathTM Imaging Systems in Gastrointestinal Tumour Surgery (CLIO)

Gastric Cancer | Pancreatic Cancer | Bile Duct Cancer | Duodenal Cancer

Hungary
Altor BioScience

Completed

A Study of ALT-836 in Combination With Gemcitabine for Locally Advanced or Metastatic Solid Tumors

Malignant Solid Tumour | Locally Advanced Malignant Neoplasm

United States
Cambridge University Hospitals NHS Foundation Trust
The Gurdon Institute; Ann McLaren Laboratory of Regenerative Medicine

Unknown

In Vitro Models of Liver and Pancreatic Cancer

Hepatocellular Carcinoma | Cholangiocarcinoma | Pancreatic Neoplasm

United Kingdom
e-Therapeutics PLC

Unknown

A Study of Dexanabinol in Combination With Chemotherapy in Patients With Advanced Tumours

Hepatocellular Carcinoma | Pancreatic Cancer

Germany, Poland, Spain, United Kingdom
Uppsala University Hospital

Completed

Effects of Dexmedetomidine During IRE Procedures for Solid Tumours

Cancer of Liver | Cancer of Pancreas

Sweden
The Leeds Teaching Hospitals NHS Trust
The Leeds Teaching Hospitals Charitable Foundation

Unknown

Evaluation of 4D-contrast Enhanced PET-CT in Tumour Volume Definition

Lung Carcinoma | Pancreatic Carcinoma | Lower Oesophageal Carcinoma

United Kingdom
AHS Cancer Control Alberta

Unknown

A Study to See if hENT1 Testing on Tumour Tissue Can Predict Response to Treatment With Gemcitabine Chemotherapy and if a Different Chemotherapy Called FOLFOX is Better Than Gemcitabine in Metastatic Pancreas Cancer (Panc001)

Metastatic Pancreas Cancer

Canada
University Hospital, Gentofte, Copenhagen
University Hospital Schleswig-Holstein; University of Medicine and Pharmacy... and other collaborators

Completed

Controlled Trial Comparing the Performance of 22 Gauge Versus 25 Gauge EUS-FNA Needles (FNA-22G-25G)

Pancreatic Masses | Liver Masses | Mediastinal Tumours and Lymph Nodes | Celiac, Perigastric and Peri-pancreatic Lymph Nodes | Adrenal Masses

Denmark, Germany, Romania
University of Colorado, Denver
AstraZeneca

Completed

Gemcitabine/Capecitabine/ZD6474 in Advanced Solid Tumors

Pancreatic Cancer | Malignant Solid Tumour | Biliary Cancer

United States
AstraZeneca

Completed

Study to Assess the Safety & Tolerability of a PARP Inhibitor in Combination With Gemcitabine in Pancreatic Cancer

Pancreatic Neoplasms

United States, United Kingdom
Baki Topal

Withdrawn

Reduced Intra-operative Blood Loss in Pancreaticoduodenectomy for Pancreatic or Peri-ampullary Tumors; Monocentric Trial on Standard Open Versus Minimally Invasive Surgery

Surgery | Pancreatic Tumour | Peri-ampullary Tumour | Blood Loss

Belgium
Mansoura University

Completed

Isolated Roux Loop Pancreaticojejunostomy Versus Pancreaticogastrostomy After Pancreaticoduodenectomy (PD)

Pancreatic Fistula After Pancreaticoduodenectomy

Egypt
Baki Topal
University Hospital, Antwerp; General Hospital Groeninge; Université Catholique... and other collaborators

Completed

Reduced Pancreatic Fistula Rate Following Pancreaticoduodenectomy: Trial on Pancreaticogastrostomy Versus Pancreaticojejunostomy

Tumors

Belgium
AstraZeneca

Completed

Safety and Tolerability Study of AZD2171 in Combination With AZD0530 in Patients With Advanced Solid Tumours

Neoplasms

Germany
Kors van der Ent
European Union

Recruiting

Clinical Trial to Evaluate the Efficacy and Safety of Dirocaftor/Posenacaftor/Nesolicaftor in Adults With CF (CHOICES)

Cystic Fibrosis

Netherlands, Spain, France, Germany, Italy, United Kingdom, Portugal, Belgium, Sweden
Casa di Cura Dott. Pederzoli
University of Padova

Recruiting

First-day Versus Early Drain Removal Following PD: a Randomized Controlled Trial (FIDEL)

Pancreas Fistula Abdominal Drains

Italy
Ruijin Hospital

Recruiting

A Trial on the Recurrence Free Survival Rate of Type I AIP With High-risk of Recurrence

Type 1 AIP

China
The First Affiliated Hospital with Nanjing Medical...

Recruiting

NALIRIFOX as Induction Therapy in LAPC

Pancreatic Ductal Adenocarcinoma

China

Search clinical trials for: pancreatic tumour

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kazakhstan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations